Clinical implications of provocation tests for coronary artery spasm: safety, arrhythmic complications, and prognostic impact: multicentre registry study of the Japanese Coronary Spasm Association

• Published in: European heart journal 2013-01, Vol.34 (4), p.258-267
• Main Authors: Takagi, Yusuke, Yasuda, Satoshi, Takahashi, Jun, Tsunoda, Ryusuke, Ogata, Yasuhiro, Seki, Atsushi, Sumiyoshi, Tetsuya, Matsui, Motoyuki, Goto, Toshikazu, Tanabe, Yasuhiko, Sueda, Shozo, Sato, Toshiaki, Ogawa, Satoshi, Kubo, Norifumi, Momomura, Shin-ichi, Ogawa, Hisao, Shimokawa, Hiroaki
• Format: Article
• Language: English
• Subjects: Acetylcholine; Aged; Arrhythmias, Cardiac - etiology; Coronary Vasospasm - diagnosis; Ergonovine; Female; Humans; Hyperventilation - physiopathology; Male; Patient Safety; Prospective Studies; Registries; Vasoconstriction - drug effects; Vasoconstrictor Agents
• ISSN: 0195-668X; 1522-9645
• DOI: 10.1093/eurheartj/ehs199

Provocation tests of coronary artery spasm are useful for the diagnosis of vasospastic angina (VSA). However, these tests are thought to have a potential risk of arrhythmic complications, including ventricular tachycardia (VT), ventricular fibrillation (VF), and brady-arrhythmias. We aimed to elucidate the safety and the clinical implications of the spasm provocation tests in the nationwide multicentre registry study by the Japanese Coronary Spasm Association. A total of 1244 VSA patients (M/F, 938/306; median 66 years) who underwent the spasm provocation tests were enrolled from 47 institutes. The primary endpoint was defined as major adverse cardiac events (MACEs). The provocation tests were performed with either acetylcholine (ACh, 57%) or ergonovine (40%). During the provocation tests, VT/VF and brady-arrhythmias developed at a rate of 3.2 and 2.7%, respectively. Overall incidence of arrhythmic complications was 6.8%, a comparable incidence of those during spontaneous angina attack (7.0%). Multivariable logistic regression analysis demonstrated that diffuse right coronary artery spasm (P < 0.01) and the use of ACh (P < 0.05) had a significant correlation with provocation-related VT/VF. During the median follow-up of 32 months, 69 patients (5.5%) reached the primary endpoint. The multivariable Cox proportional hazard model revealed that mixed (focal plus diffuse) type multivessel spasm had an important association with MACEs (adjusted hazard ratio, 2.84; 95% confidence interval, 1.34-6.03; P < 0.01), whereas provocation-related arrhythmias did not. The spasm provocation tests have an acceptable level of safety and the evaluation of spasm type may provide useful information for the risk prediction of VSA patients.